Local venous responses to endotoxin in humans

Circulation

Volumn 94, Issue 3, 1996, Pages 490-497

  Bhagat, Kiran ^a   Collier, Joe ^a   Vallance, Patrick ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

norepinephrine; shock; veins

Indexed keywords

ACETYLSALICYLIC ACID; ENDOTOXIN; GLUCOCORTICOID; HYDROCORTISONE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENDOTOXEMIA; ENZYME INHIBITION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SEPTIC SHOCK; VEIN; VENOCONSTRICTION;

EID: 0029815998     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.3.490     Document Type: Article

References (52)

1. Parriilo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328:1471-1477.
2. Snell JR, Parriilo JE. Cardiovascular dysfunction in septic shock. Chest. 1991;99:1000-1009.
3. Guc O, Furman BL, Parratt JR. Endotoxin-induced impairment of vasodepressor responses in the pithed rat. Br J Pharmacol. 1990; 101-913-919.
4. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxic shock. Cardiovasc Res. 1992;26:48-57.
5. Riethschel ET, Kirikae T, Schade FU, Mamet U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994;8:217-225.
6. Sivo J, Salkowski A, Politis AD, Vogel SN. Differential regulation of LPS-induced IL-1β and IL-1 receptor antagonist mRNA by IFN-α and IFN-γ in murine macrophages. J Endotox Res. 1994;1:300-375.
7. Hershey JC, Bond RF. Endotoxin induces metabolic dysregulation of vascular tone. Am J Physiol. 1993;265:H108-H113.
8. Liu S, Ian M, Old RW, Barnes PJ, Evans TW. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun. 1993; 196:1208-1213.
9. Granowitz EV, Porat R, Mier JW, Orencole SF, Kaplanski G, Lynch EA, Ye K, Wolff SM, Dinarello CA. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy volunteers. J Immunol. 1993;151:1637-1645.
10. Mechanic R, Frei E, Landy M, Smith WW. Quantitative studies of human leukocytic and febrile response to single and repeated doses of purified bacterial endotoxin. J Clin Invest. 1962;41:162-172.
11. Fleming I, Dambacher T, Busse R. Endothelium-derived kinins account for the immediate response of endothelial cells to bacterial lipopolysaccharide. J Cardiovasc Pharmacol. 1992;20:S135-S138.
12. Renzi PM, Flynn JT. Endotoxin enhances arachidonic acid metabolism by cultured rabbit microvascular endothelial cells. Am J Physiol. 1992;263:H1213-H1221.
13. De La Cadena RA, Suffredini AF, Page JD, Pixely RA, Kaufman N, Parrillo JE, Colman RW. Activation of the kallikrein-kinin system after endotoxin administration to normal volunteers. Blood. 1993;12: 3313-3317.
14. Klosterhalfen B, Jungemann-Horstmann K, Vogel P, Flohe S, Offner F, Kirkpatrick CJ, Heinrich PC. The time course of various inflammatory mediators during recurrent endotoxaemia. Biochem Pharmacol. 1992;43:2103-2109.
15. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989; 321:280-287.
16. Griesman SE. Induction of endotoxin tolerance. In: Nowotony A, ed. Beneficial Effects of Endotoxin. New York, NY: Plenum Publishing Corp; 1965:149-178.
17. Hoist H, Edqvist LE, Kindahl H. Reduced response to intravenous endotoxin injections following repeated oral administration of endotoxin in the pig. Acta Vet Scand. 1993;34:405-419.
18. Hosford D, Braquet M, Braquet P. Platelet-activating factor and cytokine interactions in shock. Resuscitation. 1989;18:207-218.
19. Michie HR, Manogue KR, Spriggs D, Revhaug A, O'Dwyer S, Dinnarello CA, Cerami A, Wolff SM, Wilmore DW. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;314:1481-1486.
20. Boujoukos AJ, Martich G, Supinski E, Suffredini AF. Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. J Appl Physiol. 1993;74:3027-3033.
21. 4 receptor antagonist in porcine septic shock. Eicosanoids. 1991;4:169-175.
22. McGrath JM, Stewart GJ. The effects of endotoxin on vascular endothelium. J Exp Med. 1969;129:833-848.
23. Cook HT, Bune AJ, Taylor M, Loi RK, Cartel V. Cellular localisation of inducible nitric oxide in endotoxic shock in the rat. Clin Sci (Colch). 1994;87:179-186.
24. Jeremy JY, Nystrom ML, Barradas MA, Mikhailidis DP. Eicosanoids and septicaemia. Prostaglandins Leukot Essent Fatty Acids. 1994;50: 287-297.
25. Gilbert RP. Mechanisms of the hemodynamic effects of endotoxin. Physiol Rev. 1960;40:245-279.
26. Vallance P, Palmer RMJ, Moncada S. The role of induction of nitric oxide synthesis in the altered responses of jugular veins from endotoxaemic rabbits. Br J Pharmacol. 1992;106:459-463.
27. Bradley SE, Chasis H, Goldring W, Smith HW. Hemodynamic alterations in normotensive and hypertensive subjects during the pyrogenic reaction. J Clin Invest. 1945;24:749-758.
28. Thorin-Trescases N, Hamilton C, Reid JL, Macpherson KL, Jardini E, Berg G, Bohr D, Dominiczak AF. Inducible L-arginine/nitric oxide in human internal mammary artery and saphenous vein. Am J Physiol. 1995;268:H1122-H1132.
29. Wang X, Fiscus RR, Qi M, Jones SB. Hypotension and endotoxin-induced alterations in calcitonin gene-related peptide: modulation by dexamethasone. Circ Shock. 1991;34:217-223.
30. Aellig WH. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol. 1981;11:237-243.
31. Robinson BF. Assessment of the effects of drugs on the venous system in man. Br J Clin Pharmacol. 1978;6:381-386.
32. Nachev C, Collier J, Robinson BF. Simplified method for measuring compliance of superficial veins. Cardiovasc Res. 1971;5:147-156.
33. Collier JG, Nachev C, Robinson BF. Effect of catecholamines and other vasoactive substances on the superficial hand veins in man. Clin Sci (Colch). 1972;43:455-467.
34. Benjamin N, Collier JG, Webb DJ. Angiotensin II augments sympathetically induced venoconstriction in man. Clin Sci (Colch). 1988; 75:337-340.
35. Collier J, Vallance P. Biphasic response to acetylcholine in humans in vivo: the role of the endothelium. Clin Sci (Colch). 1990;78:101-104.
36. Brandtzaeg P, Kierulf P, Gaustad R, Skulberg A, Brun JN, Halvorsen S, Sorensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 1989;159:195-204.
37. Bhagat K, Collier J, Vallance P. Vasodilatation to arachidonic acid in humans: an insight into endogenous prostanoids and effects of aspirin. Circulation. 1995;92:2113-2118.
38. Bogle RG, Baydoun AR, Pearson JD, Moncada S, Mann GE. L-Arginine transport is increased in macrophages generating nitric oxide. J Biochem. 1992;284:15-18.
39. Lewis T, Landis EM. Some physiological effects of sympathetic ganglionectomy in the human being and its effects in the case of Raynaud's malady. Heart. 1930;15:151-176.
40. Hochstein HD, Mills DF, Outshoorn AS, Rastogi SC. The processing and collaborative assay of reference endotoxin. J Biol Stand. 1983; 11:251-260.
41. Thiermermann C, Vane JR. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol. 1990;182:591-595.
42. Paya D, Gray GA, Fleming I, Stoclet JC. Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E coli lipopolysaccharide in rats. Circ Shock. 1993;41:103-112.
43. Horn GJ, Grant SK, Wolfe G, Bach TJ, Macintyre E, Hutchinson NI. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, L-NMMA or indomethacin. J Pharmacol Exp Ther. 1995;272:452-459.
44. Beasley D, McGuiggin M. Interleukin-1 activates soluble guanylate cyclase in human vascular muscle cells through a novel nitric oxide-independent pathway. J Exp Med. 1994;179:71-80.
45. Vallance P, Collier J, Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in humans in vivo. Cardiovasc Res. 1989;23:1053-1057.
46. Larkin SW, Fraser L, Williams TJ, Warren JB. Prolonged microvascular vasodilatation induced by leukotriene B4 in human skin is cyclooxygenase independent. J Pharmacol Exp Ther. 1995;272:392-398.
47. 51Cr-labeled lipid A before and after the induction of endotoxin tolerance. Proc Natl Acad Sci U S A. 1984;81:3491-3495.
48. Fahmi H, Chaby R. Desensitization of macrophages to endotoxin effects is not correlated with down-regulation of receptors of lipopolysaccharide-binding sites. Cell Immunol. 1993;150:219-229.
49. Szabo C, Thiemermann C, Wu CC, Perretti M, Vane JR. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA. 1994;91:271-275.
50. Astiz M, Rackow EC, Still JG, Howell ST, Cato A, Von Eschen KB, Ulrich JT, Rudbach JA, McMahon G, Vargas R, Stern W. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective double-blind randomized controlled trial. Crit Care Med. 1995;23:9-17.
51. Chernow B, Rainey TG, Lakey CR. Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med. 1992;10:409-416.
52. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trum-bauer M, Stevens K, Xie Q, Sokol K, Hutchinson N, Chen H, Mudg-ett JS. Altered responses to bacterial infection and endotoxin in mice lacking nitric oxide synthase. Cell. 1995;81:641-650.